Skip to main content
Top
Metadata
Title
Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma
Authors
Byung-Han Rhieu
Amol K. Narang
Jeffrey Meyer
Publication date
01-12-2019
Publisher
Springer US
Published in
Current Hepatology Reports / Issue 4/2019
Electronic ISSN: 2195-9595
DOI
https://doi.org/10.1007/s11901-019-00487-9

Other articles of this Issue 4/2019

Current Hepatology Reports 4/2019 Go to the issue

Fatty Liver Disease (V Ajmera, Section Editor)

Extrahepatic Malignancies in Nonalcoholic Fatty Liver Disease

Hepatic Cancer (N Parikh, Section Editor)

Screening Indications and Treatments for Cholangiocarcinoma

Fatty Liver Disease (V Ajmera, Section Editor)

HIV-Associated NAFLD: Disease Burden and Management

Hepatic Cancer (N Parikh, Section Editor)

Harms of Hepatocellular Carcinoma Surveillance

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine